Vale+Tú Salud corner program to help Latino day laborers prevent COVID-19
Official title: Vale+ Tu Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID 19
Run by The University of Texas Health Science Center, Houston · NCT06821113 · Data updated 2026-11-12
This program will test whether Vale+Tú Salud helps Latino day laborers increase social distancing, hand-washing, and PPE use.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | July 3, 2025 |
| Main results expected | November 1, 2025 |
| Study ends | November 1, 2025 |
| Registry record updated | August 26, 2025 |
| Trial ID | NCT06821113 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are people who self-identify as Hispanic or Latino, who gather at street corners seeking day labor and have been previously hired at those corners, and who do not have recent COVID-19 symptoms.
✕Probably not a fit
People who do not seek work at corner sites, who have not previously been hired at a corner, or who have had COVID-19 symptoms in the past 48 hours are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Vale+Tú Salud adapts a culturally tailored, corner-based outreach program for Latino day laborers and delivers group problem-solving sessions, a booster session, or standard of care across randomized corner sites. The trial gathers information on cultural, socioeconomic, interpersonal, and work-related factors that influence COVID-19 prevention behaviors. Adherence to social distancing, handwashing, and PPE use is measured one month after the intervention. The project also includes rapid, just-in-time sharing of results with organizations serving Latino immigrants to speed dissemination.
Why it matters
Potential benefit: If successful, the program could increase COVID-19 prevention behaviors among Latino day laborers and reduce their risk of infection.
How similar studies have gone: Community and peer-led behavioral programs have shown mixed but promising effects on prevention behaviors in marginalized groups, while corner-based efforts specifically for Latino day laborers and COVID-19 are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identify as Hispanic or Latino * Be present at the corner for the purposes of looking for work Exclusion Criteria: * Have not been previously hired to work at a corner * Symptoms of COVID-19 in the previous 48 hours
Where it's running
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Maria E Fernandez-Esquer, PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Maria E Fernandez-Esquer, PhD
- Email: Maria.E.Fernandez-Esquer@uth.tmc.edu
- Phone: (713) 500-9657
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults
This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.
-
Omicron-based COVID-19 vaccine with Matrix-M given as a single dose in older adults and high-risk individuals
A single-dose Omicron-subvariant vaccine with Matrix-M is tested to see if it is safe and can induce an immune response in adults 65+ and in younger adults with conditions that raise the risk of severe COVID-19, who were previously vaccinated.
-
Secutrelvir for nonhospitalized COVID-19 in teens and adults
This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.
-
Virological Monitoring of Seasonal Respiratory Infections in France
This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.
-
COVID-19 Registry at San Matteo (SMACORE) - patient-matching observational registry
This registry tests how COVID-19 patients are being treated and progress across San Matteo in Pavia to understand patterns and outcomes.
-
MDX2301 in healthy adults and adults at higher risk for severe COVID-19
This study will try single and repeat doses of MDX2301 given by IV, IM, or SC to see if they are safe and trigger neutralizing activity in healthy adults and adults at higher risk for severe COVID-19.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.